APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transconjunctival Sutureless Vitrectomy (TSV)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transconjunctival Sutureless Vitrectomy (TSV) Market Outlook and Growth Opportunities 2026

4 June 2026191 pages

Choose your research edition.

Industry ResearchTransconjunctival Sutureless Vitrectomy (TSV) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Transconjunctival Sutureless Vitrectomy (TSV) Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Transconjunctival Sutureless Vitrectomy (TSV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transconjunctival Sutureless Vitrectomy (TSV) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Transconjunctival Sutureless Vitrectomy (TSV) Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Transconjunctival Sutureless Vitrectomy (TSV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transconjunctival Sutureless Vitrectomy (TSV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transconjunctival Sutureless Vitrectomy (TSV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transconjunctival Sutureless Vitrectomy (TSV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transconjunctival Sutureless Vitrectomy (TSV) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transconjunctival Sutureless Vitrectomy (TSV) market include Bascom Palmer Eye Institute, Moorfields Eye Hospital, Massachusetts Eye and Ear Infirmary, Sichuan Provincial People's Hospital, Tongji Hospital Affiliated to Tongji University and Tianjin Medical University Eye Hospital, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Transconjunctival Sutureless Vitrectomy (TSV) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transconjunctival Sutureless Vitrectomy (TSV) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transconjunctival Sutureless Vitrectomy (TSV) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Transconjunctival Sutureless Vitrectomy (TSV) market.

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Company

Bascom Palmer Eye Institute

Moorfields Eye Hospital

Massachusetts Eye and Ear Infirmary

Sichuan Provincial People's Hospital

Tongji Hospital Affiliated to Tongji University

Tianjin Medical University Eye Hospital

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Type

25G

23G

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Application

Ophthalmology

Others

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transconjunctival Sutureless Vitrectomy (TSV) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Transconjunctival Sutureless Vitrectomy (TSV) key companies, revenue, market share, and recent developments.

3. To split the Transconjunctival Sutureless Vitrectomy (TSV) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Transconjunctival Sutureless Vitrectomy (TSV) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transconjunctival Sutureless Vitrectomy (TSV) significant trends, drivers, influence factors in global and regions.

6. To analyze Transconjunctival Sutureless Vitrectomy (TSV) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transconjunctival Sutureless Vitrectomy (TSV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transconjunctival Sutureless Vitrectomy (TSV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transconjunctival Sutureless Vitrectomy (TSV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transconjunctival Sutureless Vitrectomy (TSV) industry.

Chapter 3: Detailed analysis of Transconjunctival Sutureless Vitrectomy (TSV) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Transconjunctival Sutureless Vitrectomy (TSV) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Transconjunctival Sutureless Vitrectomy (TSV) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transconjunctival Sutureless Vitrectomy (TSV) Industry Trends Table 2. Transconjunctival Sutureless Vitrectomy (TSV) Industry Drivers Table 3. Transconjunctival Sutureless Vitrectomy (TSV) Industry Opportunities and Challenges Table 4. Transconjunctival Sutureless Vitrectomy (TSV) Industry Restraints Table 5. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Company (2021-2026) Table 7. Global Transconjunctival Sutureless Vitrectomy (TSV) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Transconjunctival Sutureless Vitrectomy (TSV) Key Company Manufacturing Base & Headquarters Table 9. Global Transconjunctival Sutureless Vitrectomy (TSV) Company, Product Type & Application Table 10. Global Transconjunctival Sutureless Vitrectomy (TSV) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Transconjunctival Sutureless Vitrectomy (TSV) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 25G Table 15. Significant Companies of 23G Table 16. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type (2021-2026) Table 20. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Ophthalmology Table 22. Significant Companies of Others Table 23. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application (2021-2026) Table 27. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application (2027-2032) Table 28. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Region (2021-2026) Table 31. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Region (2027-2032) Table 33. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Market Share by Country (2021-2026) Table 36. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Market Share by Country (2027-2032) Table 38. Bascom Palmer Eye Institute Company Information Table 39. Bascom Palmer Eye Institute Business Overview Table 40. Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 42. Bascom Palmer Eye Institute Recent Development Table 43. Moorfields Eye Hospital Company Information Table 44. Moorfields Eye Hospital Business Overview Table 45. Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 47. Moorfields Eye Hospital Recent Development Table 48. Massachusetts Eye and Ear Infirmary Company Information Table 49. Massachusetts Eye and Ear Infirmary Business Overview Table 50. Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 52. Massachusetts Eye and Ear Infirmary Recent Development Table 53. Sichuan Provincial People's Hospital Company Information Table 54. Sichuan Provincial People's Hospital Business Overview Table 55. Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 57. Sichuan Provincial People's Hospital Recent Development Table 58. Tongji Hospital Affiliated to Tongji University Company Information Table 59. Tongji Hospital Affiliated to Tongji University Business Overview Table 60. Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 62. Tongji Hospital Affiliated to Tongji University Recent Development Table 63. Tianjin Medical University Eye Hospital Company Information Table 64. Tianjin Medical University Eye Hospital Business Overview Table 65. Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 67. Tianjin Medical University Eye Hospital Recent Development Table 68. Research Programs/Design for This Report Table 69. Authors List of This Report Table 70. Secondary Sources Table 71. Primary Sources List of Figures Figure 1. Transconjunctival Sutureless Vitrectomy (TSV) Product Image Figure 2. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032) & (US$ Million) Figure 4. Global Transconjunctival Sutureless Vitrectomy (TSV) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 25G Image Figure 8. 23G Image Figure 9. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type (2021-2032) Figure 12. Ophthalmology Image Figure 13. Others Image Figure 14. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application (2021-2032) Figure 17. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032) & (US$ Million) Figure 20. North America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032) & (US$ Million) Figure 26. South America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • 25G
  • 23G
Applications
  • Ophthalmology
  • Others
Companies covered
  • Bascom Palmer Eye Institute
  • Moorfields Eye Hospital
  • Massachusetts Eye and Ear Infirmary
  • Sichuan Provincial People's Hospital
  • Tongji Hospital Affiliated to Tongji University
  • Tianjin Medical University Eye Hospital

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Transconjunctival Sutureless Vitrectomy (TSV) Market Dynamics
  1. 2.1 Transconjunctival Sutureless Vitrectomy (TSV) Industry Trends
  2. 2.2 Transconjunctival Sutureless Vitrectomy (TSV) Industry Drivers
  3. 2.3 Transconjunctival Sutureless Vitrectomy (TSV) Industry Opportunities and Challenges
  4. 2.4 Transconjunctival Sutureless Vitrectomy (TSV) Industry Restraints
3 Transconjunctival Sutureless Vitrectomy (TSV) Market by Company
  1. 3.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Company Revenue Ranking in 2025
  2. 3.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Company (2021-2026)
  3. 3.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Company Ranking (2024-2026)
  4. 3.4 Global Transconjunctival Sutureless Vitrectomy (TSV) Company Manufacturing Base and Headquarters
  5. 3.5 Global Transconjunctival Sutureless Vitrectomy (TSV) Company Product Type and Application
  6. 3.6 Global Transconjunctival Sutureless Vitrectomy (TSV) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Transconjunctival Sutureless Vitrectomy (TSV) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Transconjunctival Sutureless Vitrectomy (TSV) Market by Type
  1. 4.1 Transconjunctival Sutureless Vitrectomy (TSV) Type Introduction
  2. 4.1.1 25G
  3. 4.1.2 23G
  4. 4.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type
  5. 4.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type (2021-2032)
5 Transconjunctival Sutureless Vitrectomy (TSV) Market by Application
  1. 5.1 Transconjunctival Sutureless Vitrectomy (TSV) Application Introduction
  2. 5.1.1 Ophthalmology
  3. 5.1.2 Others
  4. 5.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application
  5. 5.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application (2021-2032)
6 Transconjunctival Sutureless Vitrectomy (TSV) Regional Value Analysis
  1. 6.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032)
  7. 6.3.2 North America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032)
  10. 6.4.2 Europe Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032)
  16. 6.6.2 South America Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Country, 2025 VS 2032
7 Transconjunctival Sutureless Vitrectomy (TSV) Country-level Value Analysis
  1. 7.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Transconjunctival Sutureless Vitrectomy (TSV) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bascom Palmer Eye Institute
  2. 8.1.1 Bascom Palmer Eye Institute Company Information
  3. 8.1.2 Bascom Palmer Eye Institute Business Overview
  4. 8.1.3 Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  6. 8.1.5 Bascom Palmer Eye Institute Recent Developments
  7. 8.2 Moorfields Eye Hospital
  8. 8.2.1 Moorfields Eye Hospital Company Information
  9. 8.2.2 Moorfields Eye Hospital Business Overview
  10. 8.2.3 Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  12. 8.2.5 Moorfields Eye Hospital Recent Developments
  13. 8.3 Massachusetts Eye and Ear Infirmary
  14. 8.3.1 Massachusetts Eye and Ear Infirmary Company Information
  15. 8.3.2 Massachusetts Eye and Ear Infirmary Business Overview
  16. 8.3.3 Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  18. 8.3.5 Massachusetts Eye and Ear Infirmary Recent Developments
  19. 8.4 Sichuan Provincial People's Hospital
  20. 8.4.1 Sichuan Provincial People's Hospital Company Information
  21. 8.4.2 Sichuan Provincial People's Hospital Business Overview
  22. 8.4.3 Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  24. 8.4.5 Sichuan Provincial People's Hospital Recent Developments
  25. 8.5 Tongji Hospital Affiliated to Tongji University
  26. 8.5.1 Tongji Hospital Affiliated to Tongji University Company Information
  27. 8.5.2 Tongji Hospital Affiliated to Tongji University Business Overview
  28. 8.5.3 Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  30. 8.5.5 Tongji Hospital Affiliated to Tongji University Recent Developments
  31. 8.6 Tianjin Medical University Eye Hospital
  32. 8.6.1 Tianjin Medical University Eye Hospital Company Information
  33. 8.6.2 Tianjin Medical University Eye Hospital Business Overview
  34. 8.6.3 Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  36. 8.6.5 Tianjin Medical University Eye Hospital Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst